SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-065119
Filing Date
2017-12-22
Accepted
2017-12-22 16:30:38
Documents
2
Period of Report
2017-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv481895_8k.htm 8-K 18976
2 EXHIBIT 4.4 tv481895_ex4-4.htm EX-4.4 12206
  Complete submission text file 0001144204-17-065119.txt   32429
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-20713 | Film No.: 171272981
SIC: 2836 Biological Products, (No Diagnostic Substances)